| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.31 | 8e-08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |